Sato Pharmaceutical Inc. recalls Zentrip (meclizine Hydrochloride), 25 mg strips, 8-strips per box, Distributed by Sato Pharmaceutical INC. 20695 S. Wes…
- Recall date
- October 1, 2019
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0322-2020
- FDA classification
- Class III
- Brand / firm
- Sato Pharmaceutical Inc.
- Sold / distributed
- Nationwide within the United States, Guam and Saipan
Why it was recalled
Subpotent Drug
Class III means the product violates regulations but is not likely to cause harm.
What was recalled
Zentrip (meclizine Hydrochloride), 25 mg strips, 8-strips per box, Distributed by Sato Pharmaceutical INC. 20695 S. Western Ave., Suite 240 Torrence, CA 90501, NDC 49873-803-01. UPC 4987301603
Get recall alerts
Free email alert whenever Sato Pharmaceutical Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Sato Pharmaceutical Inc.